A Comparative Study of Clinical Utility of Spot Urine Samples with 24-h Urine Albumin Excretion for Screening of Microalbuminuria in Type 2 Diabetic Patients
- PMID: 22754194
- PMCID: PMC3162961
- DOI: 10.1007/s12291-011-0136-0
A Comparative Study of Clinical Utility of Spot Urine Samples with 24-h Urine Albumin Excretion for Screening of Microalbuminuria in Type 2 Diabetic Patients
Abstract
Twenty-four hour urinary albumin excretion (UAE) is considered as gold standard method for albuminuria measurement, but collection of 24-h urine is inconvenient. The aim of present study was to evaluate whether albumin: creatinine ratio (ACR) and urinary albumin concentration (UAC) in different spot urine samples correlate or not with 24-h UAE for screening of microalbuminuria in type 2 diabetic patients. We collected first morning void (FMV), random urine sample (RUS) and 24-h urine, separately on consecutive days from 104 type 2 diabetic patients. ACR and UAC in each spot urine sample compared with 24-h UAE with regard to Pearson correlation coefficient. Pearson's correlation of albumin: creatinine ratio (ACR) with 24-h UAE was (r = 0.802 and 0.623) in first morning void (FMV) and random urine sample (RUS), respectively. Pearson's correlation coefficient of urinary albumin concentration (UAC) compared with 24-h UAE was (r = 0.943 and 0.920), in FMV and RUS, respectively, P < 0.01. Results revealed that values in first morning void (FMV) were better correlated with 24-h urinary albumin excretion (UAE), than the values in random urine sample (RUS). We conclude that the first morning void (FMV) may be able to replace 24-h urine collection, preferably urinary albumin concentration (UAC) in the initial screening of microalbuminuria in diabetic patients.
Electronic supplementary material: The online version of this article (doi:10.1007/s12291-011-0136-0) contains supplementary material, which is available to authorized users.
Keywords: Diabetes mellitus; Microalbuminuria; Screening; Spot urine sample; Urinary albumin concentration.
Figures




Similar articles
-
Why 24-h Urine Albumin Excretion Rate Method Still is Used for Screening of Diabetic Nephropathy in Isfahan Laboratories?Int J Prev Med. 2014 Mar;5(3):341-7. Int J Prev Med. 2014. PMID: 24829719 Free PMC article.
-
First morning voids are more reliable than spot urine samples to assess microalbuminuria.J Am Soc Nephrol. 2009 Feb;20(2):436-43. doi: 10.1681/ASN.2008030292. Epub 2008 Dec 17. J Am Soc Nephrol. 2009. PMID: 19092125 Free PMC article.
-
The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population.Kidney Int Suppl. 2005 Apr;(94):S28-35. doi: 10.1111/j.1523-1755.2005.09408.x. Kidney Int Suppl. 2005. PMID: 15752236 Clinical Trial.
-
Screening for microalbuminuria: which measurement?Diabet Med. 1991 Oct;8(8):706-11. doi: 10.1111/j.1464-5491.1991.tb01688.x. Diabet Med. 1991. PMID: 1838060 Review.
-
The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.Ann Med. 1997 Oct;29(5):439-45. doi: 10.3109/07853899708999374. Ann Med. 1997. PMID: 9453292 Review.
Cited by
-
Why 24-h Urine Albumin Excretion Rate Method Still is Used for Screening of Diabetic Nephropathy in Isfahan Laboratories?Int J Prev Med. 2014 Mar;5(3):341-7. Int J Prev Med. 2014. PMID: 24829719 Free PMC article.
-
Do not forget the kidney in graves' disease.Int Urol Nephrol. 2023 Oct;55(10):2667-2673. doi: 10.1007/s11255-023-03600-6. Epub 2023 Apr 24. Int Urol Nephrol. 2023. PMID: 37093438
-
Association of microalbuminuria with left ventricular dysfunction in Nigerian normotensive type 2 diabetes patients.Cardiovasc J Afr. 2018 Sep/Oct 23;29(5):283-288. doi: 10.5830/CVJA-2018-026. Epub 2018 Jun 13. Cardiovasc J Afr. 2018. PMID: 30059127 Free PMC article.
References
-
- David B, Sacks MB. Carbohydrates. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry & molecular diagnostics. 4. St.Louis, Missouri: Elsevier; 2006. pp. 886–888.
-
- Molitch ME, DeFronozo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, et al. American Diabetes Association: diabetic nephropathy. Position statement. Diabetes Care. 2003;26(suppl 1):S94–S98. - PubMed
-
- The Diabetes Control and Complications (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. Kidney Int 1995;47(6):1703–20. - PubMed
LinkOut - more resources
Full Text Sources